Merck Cancer Drug Fails Trial - Breaking News Allvoices

News Stories Related To: Merck Cancer Drug Fails Trial

Singapore : Singapore | 2 years ago  
Merck KGaA suffered another setback for its cancer drug Erbitux, which in a trial failed to significantly increase the length of time advanced gastric cancer patients live without...
    • Clear
    • Share:
    • Share
    • Clear
    • Clear
    • Clear
    • Clear
  • Read full report
Credibility Credibility of 3

Related news stories

  • Merck KGaA suffers setback on cancer drug

      Channel NewsAsia | 2 years ago
    German pharmaceuticals maker Merck KGaA said on Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients. The trials found that in combination with standard chemotherapy, Erbitux did not extend "...

Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.